The melatonin immunomodulatory actions in radiotherapy

Area of Science:

• Oncology
• Immunology
• Radiotherapy

Background:

• Radiotherapy is crucial for cancer treatment, but severe side effects limit its efficacy.
• Immune system responses significantly influence radiation-induced side effects and tumor response.
• Melatonin, an antioxidant, possesses immune-regulatory properties with potential to mitigate radiation toxicity.

Purpose of the Study:

• To review the effects of melatonin on immune responses in normal and tumor tissues during radiotherapy.
• To explore melatonin's potential to ameliorate radiation-induced toxicity and enhance anti-tumor effects.

Main Methods:

• Review of scientific literature on melatonin's effects on radiation biology and immunology.
• Analysis of melatonin's mechanisms of action, including DNA repair, antioxidant enzymes, and immune cell modulation.
• Examination of clinical data on melatonin's application in cancer treatment.

Main Results:

• Melatonin modulates immune responses at various levels, impacting tissue reactions to ionizing radiation.
• It influences DNA repair, antioxidant enzymes, cytokine secretion, and immune cell activity.
• Melatonin exhibits anti-cancer properties, including anti-proliferative and anti-angiogenic effects, potentially improving radiotherapy outcomes.

Conclusions:

• Melatonin shows promise in managing radiotherapy side effects and enhancing treatment efficacy.
• Its immune-modulatory and anti-tumor effects warrant further investigation for clinical application.
• Melatonin may improve the therapeutic ratio of radiotherapy by protecting normal tissues and boosting anti-tumor immunity.